Related Articles
Therapeutic window for YC‑1 following glutamate‑induced neuronal damage and transient focal cerebral ischemia
YC‑1 reduces inflammatory responses by inhibiting nuclear factor‑κB translocation in mice subjected to transient focal cerebral ischemia
ATPase inhibitory factor 1 inhibition improves the antitumor of YC‑1 against hepatocellular carcinoma
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)